Heart failure & cardiomyopathiesCohort study

A No-Code, Guideline-Based Custom Generative Pretrained Transformer (GPT) Outperforms Cardiologists in Response Quality for Cardiac Amyloidosis

JACC AdvPublication date not resolved

  • prospective, blinded, comparative study

Authors' conclusion

A no-code, guideline-based custom GPT delivered superior response quality to that of cardiologists for CA questions. This approach allows clinicians without programming skills to build disease-specific large language models, potentially supporting equitable care where specialist access is limited. However, further studies are needed to evaluate potentially inaccurate outputs such as hallucinations.

Study context

Population
Clinical questions regarding cardiac amyloidosis generated by nonspecialist physicians
Participants
71 unique clinical questions
Exposure
AmyloGPT vs board-certified cardiologist answers

Main finding

As reported in the abstract

Preference (forced-choice) for AmyloGPT

Preferred by nonspecialist evaluators

81.1% (95% CI: 78.1%-83.8%)

Preferred by cardiologist evaluators

83.6% (95% CI: 78.6%-88.6%)

Observational data: associations, not effects.

Further findings

Median ratings for intent alignment and clinical usefulness (nonspecialist evaluators)

Higher with AmyloGPT
both P < 0.001

Median ratings for accuracy, consistency, validity, completeness, and absence of bias (cardiologist evaluators)

Higher with AmyloGPT
all P < 0.001

Original publication

A No-Code, Guideline-Based Custom GPT Outperforms Cardiologists in Response Quality for Cardiac Amyloidosis. JACC Adv. doi:10.1016/j.jacadv.2026.102918

Summarised from the published abstract; every number is checked against it